ArticleBlood2013

Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia.

Bo Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.